David R Guyer is of EyePoint Pharmaceuticals, Inc.. Currently has a direct ownership of 1,850 shares of EYPT, which is worth approximately $11,747. The most recent transaction as insider was on Jul 12, 2024, when has been sold 11,625 shares (Common Stock) at a price of $10.06 per share, resulting in proceeds of $116,947. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.85K
0% 3M change
75.0% 12M change
Total Value Held $11,747

DAVID R GUYER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 12 2024
SELL
Open market or private sale
$116,947 $10.06 p/Share
11,625 Reduced 86.27%
1,850 Common Stock
Jul 12 2024
BUY
Exercise of conversion of derivative security
$33,039 $3.38 p/Share
9,775 Added 42.04%
13,475 Common Stock
Jun 03 2024
SELL
Open market or private sale
$119,737 $10.3 p/Share
11,625 Reduced 75.86%
3,700 Common Stock
Jun 03 2024
BUY
Exercise of conversion of derivative security
$33,039 $3.38 p/Share
9,775 Added 38.94%
15,325 Common Stock
May 14 2024
SELL
Open market or private sale
$147,056 $12.65 p/Share
11,625 Reduced 67.69%
5,550 Common Stock
May 14 2024
BUY
Exercise of conversion of derivative security
$33,039 $3.38 p/Share
9,775 Added 36.27%
17,175 Common Stock
Feb 09 2023
BUY
Exercise of conversion of derivative security
-
3,000 Added 28.85%
7,400 Common Stock
Feb 09 2022
BUY
Exercise of conversion of derivative security
-
2,500 Added 36.23%
4,400 Common Stock
Feb 28 2021
BUY
Exercise of conversion of derivative security
-
1,900 Added 50.0%
1,900 Common Stock

Also insider at

ISEE
IVERIC bio, Inc. Healthcare
DRG

David R Guyer

New York, NY

Track Institutional and Insider Activities on EYPT

Follow EyePoint Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EYPT shares.

Notify only if
Any

Insider Trading

Get notified when an Eye Point Pharmaceuticals, Inc. insider buys or sells EYPT shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to EyePoint Pharmaceuticals, Inc.

Track Activities on EYPT